seranovo.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: /admin/ Sitemap: | ||
Meta Tags
| Title | SeraNovo |
| Description | Next Generation Bioavailability SeraNovo is a pharmaceutical formulation company focused on increasing oral bioavailability of poorly soluble APIs using deep eutectic solvent |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 91.184.0.44 |
| Location | Netherlands |
Related Websites
| Site | Rank |
More to Explore
seranovo.com Valuation
|
US$2,185,471
Last updated: 2023-05-17 09:48:13
seranovo.com has Semrush global rank of 4,843,031. seranovo.com has an estimated worth of US$ 2,185,471, based on its estimated Ads revenue. seranovo.com receives approximately 252,170 unique visitors each day. Its web server is located in Netherlands, with IP address 91.184.0.44. According to SiteAdvisor, seranovo.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$2,185,471 |
| Daily Ads Revenue | US$2,018 |
| Monthly Ads Revenue | US$60,521 |
| Yearly Ads Revenue | US$726,249 |
| Daily Unique Visitors | 16,812 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| seranovo.com. | A | 14399 | IP: 91.184.0.44 |
| seranovo.com. | NS | 14400 | NS Record: ns3.hostnetbv.nl. |
| seranovo.com. | NS | 14400 | NS Record: ns2.hostnetbv.com. |
| seranovo.com. | NS | 14400 | NS Record: ns1.hostnet.nl. |
| seranovo.com. | MX | 14400 | MX Record: 10 mailfilter.hostnet.nl. |
| seranovo.com. | TXT | 3600 | TXT Record: v=spf1 a mx include:_spf.hostnet.nl -all |
| seranovo.com. | TXT | 3600 | TXT Record: MS=ms12293825 |
HtmlToTextCheckTime:2023-05-17 09:48:13
| Open menu Technology Services Team News Press releases Resources Careers Contact Next Generation Bioavailability Enhancement SeraNovo is a formulation technology provider enhancing the bioavailability of poorly soluble API’s. Our team is specialized in addressing two core issues with our proprietary technology: enhancing bioavailability and reducing development time to the clinic. SeraNovo is purpose-built to solve these issues. Contact us Leiden, May 15th, 2023: SeraNovo and AstraZeneca to collaborate on research projects SeraNovo (Leiden, The Netherlands) is pleased to announce the closing of a multi compound deal with AstraZeneca (Cambridge, United Kingdom) Read more The benefits of our technology Bioavailability Enhancement Our state-of-the-art proprietary eutectic formulation technology is a proven approach for significantly enhancing the bioavailability of even the most difficult to formulate APIs. Rapid Formulation Development The quality of our formulations is matched by our |
HTTP Headers
HTTP/1.1 302 Found Server: nginx/1.20.2 Date: Fri, 18 Mar 2022 09:51:39 GMT Content-Type: text/html; charset=iso-8859-1 Location: https://seranovo.com/ Cache-Control: max-age=0 Expires: Fri, 18 Mar 2022 09:51:39 GMT HTTP/2 200 server: nginx/1.20.2 date: Fri, 18 Mar 2022 09:51:40 GMT content-type: text/html; charset=UTF-8 vary: Accept-Encoding x-powered-by: PHP/7.2.34 cache-control: private, no-cache, no-store, proxy-revalidate, no-transform x-frame-options: SAMEORIGIN pragma: no-cache |
seranovo.com Whois Information
Domain Name: SERANOVO.COM Registry Domain ID: 2093459432_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.tucows.com Registrar URL: http://www.tucows.com Updated Date: 2021-12-29T06:38:13Z Creation Date: 2017-01-27T08:40:05Z Registry Expiry Date: 2023-01-27T08:40:05Z Registrar: Tucows Domains Inc. Registrar IANA ID: 69 Registrar Abuse Contact Email: domainabuse@tucows.com Registrar Abuse Contact Phone: +1.4165350123 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS1.HOSTNET.NL Name Server: NS2.HOSTNETBV.COM Name Server: NS3.HOSTNETBV.NL DNSSEC: unsigned >>> Last update of whois database: 2022-03-18T10:28:13Z <<< |